XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.4
Revenue (Tables)
 12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The table below provides the disaggregation of revenue by type (in thousands):
Years Ended December 31,
202520242023
Dermatologic(1)
$216,369 $256,996 $183,375 
Non-Dermatologic(2)
127,860 75,073 36,413 
Total net revenues$344,229 $332,069 $219,788 
(1)Consists of DecisionDx-Melanoma, DecisionDx-SCC and MyPath Melanoma.
(2)Consists of TissueCypher, DecisionDx-UM and IDgenetix.
Schedules of Concentration of Risk, by Risk Factor
Our significant third-party payors and their related revenues, each of which accounted for more than 10% of total revenues or accounts receivable balances were as follows:
 Percentage of Revenues
Percentage of
 Accounts Receivable
 (current)
Percentage of
 Accounts Receivable
 (noncurrent)
 
Years Ended December 31,
As of December 31,As of December 31,
 2025202420232025202420252024
Medicare44 %47 %49 %18 %18 %**
Payor A16 %15 %14 %15 %19 %16 %15 %
Payor B***22 %20 %10 %12 %
*    Less than 10%